Latest Merck Stories
Collective Voice of Community Embodies Culmination of "Getting Vocal" About Individualized Treatment around the Country WHITEHOUSE STATION, N.J., Dec.
Ariad Pharmaceuticals, Inc. - Product Pipeline Review - 2014 LONDON, Nov. 20, 2014 /PRNewswire/ -- Summary Global Markets Direct's, 'Ariad Pharmaceuticals, Inc.
All six trials met primary efficacy endpoint TARRYTOWN, N.Y. and PARIS, Nov. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
-- Permits quantitative, statistically robust assessment of NFkB translocation DARMSTADT, Germany, Nov.
RESEARCHERS FIND RARE, LOSS-OF-FUNCTION MUTATIONS THAT LOWER BLOOD CHOLESTEROL AND REDUCE RISK OF HEART ATTACK CAMBRIDGE, Mass., Nov.
Culinary Expert Visits Los Angeles on November 9 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J., Nov.
- Increased performance provides better sensitivity and resolution DARMSTADT, Germany, Nov.
The Case Management Order extends deadlines for the Tier II, III, and IV Femur Fracture Discovery Pools. Port Washington, NY (PRWEB) November 04, 2014
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.